UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 337

Sortiert nach

Hypoxia promotes stem cell-like phenotype in multiple myeloma cells

Blood cancer journal (New York), 2014-12, Vol.4 (12), p.e262-e262

2014

Volltextzugriff (PDF)

Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib

Leukemia, 2012-05, Vol.26 (5), p.985-990

2012

Volltextzugriff (PDF)

The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression

Leukemia, 2013-04, Vol.27 (4), p.961-964

2013

Volltextzugriff (PDF)

MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

Blood cancer journal (New York), 2016-02, Vol.6 (2), p.e399-e399

2016

Volltextzugriff (PDF)

In vitro and in vivo analysis of pulsatile biodegradation of mucoadhesive hydrogels

Journal of drug delivery science and technology, 2009, Vol.19 (4), p.247-255

2009

Volltextzugriff (PDF)

Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination

Blood cancer journal (New York), 2014-04, Vol.4 (4), p.e204-e204

2014

Volltextzugriff (PDF)

Theoretical investigation of the performance of integrated seawater desalination plant utilizing renewable energy

Energy conversion and management, 2016-10, Vol.126, p.811-825

2016

Volltextzugriff (PDF)

Contemporary drug therapies for multiple myeloma

Drugs of today (Barcelona, Spain : 1998), 2013-09, Vol.49 (9), p.563

2013

Volltextzugriff (PDF)

Spotlight on ixazomib: potential in the treatment of multiple myeloma

Drug design, development and therapy, 2016-01, Vol.10 (Issue 1), p.217-226

2016

Volltextzugriff (PDF)

Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma

Haematologica (Roma), 2016-07, Vol.101 (7), p.e307

2016

Volltextzugriff (PDF)

Hypoxia promotes stem cell-like phenotype in multiple myeloma cells

Blood cancer journal (New York), 2014-12, Vol.4, p.e262

2014

Volltextzugriff (PDF)

Crosslinked chitosan implants as potential degradable devices for brachytherapy: In vitro and in vivo analysis

Journal of controlled release, 2006-04, Vol.111 (3), p.281-289

2006

Volltextzugriff (PDF)

Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymers

Journal of controlled release, 2005-08, Vol.106 (1), p.14-25

2005

Volltextzugriff (PDF)

Phase I Trial of Plerixafor and Bortezomib As a Chemosensitization Strategy in Relapsed or Relapsed/Refractory Multiple Myeloma

Blood, 2011-11, Vol.118 (21), p.1874-1874

2011

Volltextzugriff (PDF)

Role of Proteasome Inhibition in Waldenstroem's Macroglobulinemia

Clinical lymphoma & myeloma, 2009-02, Vol.9 (1), p.94-96

2009

Volltextzugriff (PDF)

Modeling the viscous wall region

The Physics of fluids (1958), 1987-08, Vol.30 (8), p.2362-2373

1987

Volltextzugriff (PDF)

Contemporary drug therapies for multiple myeloma

Drugs of today (Barcelona, Spain : 1998), 2013-09, Vol.49 (9), p.563-573

2013

Volltextzugriff (PDF)

Novel Therapeutic Agents in Waldenstroem's Macroglobulinemia

Clinical lymphoma & myeloma, 2009-02, Vol.9 (1), p.84-86

2009

Volltextzugriff (PDF)

Chapter 5 Boron neutron capture therapy

Studies in Inorganic Chemistry, 2006, Vol.22, p.337-366

2006

Volltextzugriff (PDF)

B528 Dual PI3K and mTOR Inhibition in Waldenström Macroglobulinemia

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S144-S145

2009

Volltextzugriff (PDF)

B615 The Role of RTK's in Waldenström Macroglobulinemia

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S158-S159

2009

Volltextzugriff (PDF)

B536 Gene Transcriptional Activity Analysis of the 6q Region in Waldenström Macroglobulinemia

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S145-S145

2009

Volltextzugriff (PDF)

B527 The Tyrosine Kinase Src Regulates Adhesion and Survival in Waldenström Macroglobulinemia

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S144-S144

2009

Volltextzugriff (PDF)

B581 MicroRNA Regulate Growth and Angiogenesis in Multiple Myeloma

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S153-S154

2009

Volltextzugriff (PDF)

B622 Rho-A and Rac-1 GTPases in Multiple Myeloma

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S159-S159

2009

Volltextzugriff (PDF)

1 – 25 von 337

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(297)
Mit Volltextzugriff
(293)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Hypoxia promotes stem cell-like phenotype in multiple myeloma cells

Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib

The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression

MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

In vitro and in vivo analysis of pulsatile biodegradation of mucoadhesive hydrogels

Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination

Theoretical investigation of the performance of integrated seawater desalination plant utilizing renewable energy

Contemporary drug therapies for multiple myeloma

Spotlight on ixazomib: potential in the treatment of multiple myeloma

Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma

Hypoxia promotes stem cell-like phenotype in multiple myeloma cells

Crosslinked chitosan implants as potential degradable devices for brachytherapy: In vitro and in vivo analysis

Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymers

Phase I Trial of Plerixafor and Bortezomib As a Chemosensitization Strategy in Relapsed or Relapsed/Refractory Multiple Myeloma

Role of Proteasome Inhibition in Waldenstroem's Macroglobulinemia

Modeling the viscous wall region

Contemporary drug therapies for multiple myeloma

Novel Therapeutic Agents in Waldenstroem's Macroglobulinemia

Chapter 5 Boron neutron capture therapy

B528 Dual PI3K and mTOR Inhibition in Waldenström Macroglobulinemia

B615 The Role of RTK's in Waldenström Macroglobulinemia

B536 Gene Transcriptional Activity Analysis of the 6q Region in Waldenström Macroglobulinemia

B527 The Tyrosine Kinase Src Regulates Adhesion and Survival in Waldenström Macroglobulinemia

B581 MicroRNA Regulate Growth and Angiogenesis in Multiple Myeloma

B622 Rho-A and Rac-1 GTPases in Multiple Myeloma

Suchergebnisse filtern